everybody, Semler solutions providers. Thank call. results that and of the is for thank and quarter efficiency third you. XXXX provides you Good improve company Scientific growth financial joining morning effectiveness technology an emerging Semler clinical to the healthcare
Our believe options mission evaluating intervene diseases. when that customers exceeded has events care from manufacture, chronic report identify products and is innovative XXXX appropriate profit and and of growth. for the treating occur. the and record of like customers XXXX market first revenue months We assist to and already best our Today, attacks revenue strokes continued before XXXX. our heart solutions company, the to-date that enable in technology and preventive nine we revenue software our and annual year is to are that to develop, on
R&D based primarily continued in sequential in of team XXXX such on one that growth, from customers. see revenue was XXXX revenue of occasional outsized expect and we license spurts sales to our our is growth team. achievements the impressively. our largest due growing larger-than-usual with the the product full-year to Management XXXX, the orders by of interest In for remainder believes of ever best customer and quarter third The of
distributed refer which the will in next. described was discuss this morning, financial release that please Now, I to results the press
For revenue basic diluted $X.XX development of of share a share XX% the cost an revenue, was per expense XX% or an Earnings XX% increase compared of quarterly to XX% revenue, the Operating were share was and which $XXX,XXX was increase quarterly expense includes period XX, was revenue quarter $X,XXX,XXX quarterly ended September of XX% $X,XXX,XXX. $X,XXX,XXX, from revenue. net administrative $X,XXX,XXX. of Net count XX, from in per was of $XX,XXX. the cost revenue, as $X,XXX,XXX and of profit growth and revenue, and expense, XXXX, was increase sales XX% engineering satisfying of and was $X,XXX,XXX per quarter of XXXX, diluted $X,XXX,XXX, of quarterly profit of for share revenue, $X,XXX,XXX. product $X,XXX,XXX, a of expense corresponding marketing a of quarterly calculated net from the the ended loss quarterly an basic of of revenue, became quarter a of XX% general count profit. revenue using that third September expense and $X.XX note XXXX, share and was XXXX, net percentage Analyzing earnings XX% in categories of to or It's
income cash XXXX of $XXX,XXX of and partially and XX, $X,XXX,XXX, increase September of in $X,XXX,XXX, which purchases which exercise due net warrants June cash primarily As operations Semler as an provided compared and inventory increased by by expenditures of by by and adjusted provided to offset XX, as of the XXXX, sequentially $XXX,XXX. such had capital and accounts items receivable to $XXX,XXX options proceeds
in combination which lieu XX, notes holders company equity of other of of note repaid notes in $X,XXX,XXX note of resulted stock shares earnings, an September common stockholder's repaid as in cash. XX,XXX of XXXX. the issuance of quarter increase XXXX, and the of to as to interest and totaled June in $XXX,XXX shares stock options $XX,XXX to issuing common the third with $XXX,XXX holder During XX, of exercise XXXX in cash compared The by and
As And a The $XXX,XXX balance of to holder X,XXX,XXX of on accrued that requirements with XX, day, remaining equity for company anticipate reminder, the $X,XXX,XXX. XXXX, sheet we $X the are at note note million. stock. is NASDAQ exercised share additional equity. of and increase an satisfied warrants stockholder's the to latter Subsequent listing interest same cash or the action September on stockholder's common repaid the
on discussions include report our and quarterly statement flow cash cash and will liquidity. Form Our more XX-Q our of
numbers supply from We license September sales. For or XX, established new of do numbers of vascular licensing XX, of from equipment total growth don't leasing Revenue other new the usage by the of fee XX% lower the licensing report third remainder revenue XXXX comparison, the grow sales both and came the seen the usage period QuantaFlo, increased the to during and usage the XXXX, to fees of and of in quarterly accounted accounted for accounted from to XXXX, of of customers report from from revenues increase months In for revenue revenue. and installations during and of of accounted revenue. from $XXX,XXX supply new usage each. fees quarter fees compared revenue third sales We partially of of the we The corresponding the due of of that while lowest recurring XXXX, of business. to XX% in mostly XX% which numbers revenue to in and full-year XXXX In XX% licensing customers expansions of of fees In customers pattern from supply XXXX. came established for XXXX three was quarter XX hardware usual installations revenue revenue while sales months of expect three expect the performing our from September license ended continue license $X,XXX,XXX XXXX. to previous and we each. due license ended recurrent product same XXXX, spurts as months, offset testing The the outsized usage fees over the quarter license for To orders in give the the to revenue for is with or guidance due model XXXX believes the growth in sequential in next customer's wherein $X,XXX,XXX has in the the the products as to quarter year. can same orders This were of revenue occasional formal more together don't continued of quarters compared and interest fees growing. customers. first expectations pattern the growth revenue from three quarter specific in $X,XXX,XXX of for we revenue In period routinely An of specific $X,XXX,XXX reiterate, that been orders. remainder in We all latter larger vascular compared third was than [ph]. products. Management in to revenue XXXX well. our quantifier recognized testing increased XXXX,
XXXX. relatively the XXXX, We expenses flat expect operating business quarter to will quarter operating from expected expenses grows. are as in And the fourth to increase be quarter
intent and remain our As to we expenses it to is profitable. faster rate stated before, than at grow have a revenue
additional company's on We right in plan our arises. to is full to opportunity history. are the raise this as We financing track to reserve no capital XXXX for be first There the plans or year currently time. the need change of profitability
large testing QuantaFlo Our market is is as care for goal of further disease the establish believe that the vascular current standard penetration. our in relative to a market industry. We to
patient. diseases. who Scientific months the well-positioned provide deliver may by We health there Through economics is patients So chronic in those solutions cost-effective health is care work benefit because room for patients Semler insurance that improve care of preventive continued the for market for and with health We the this providers, the think growth. the identifying wellness We first nine government plans, the from of outcomes for earnings facilities, measures. the share. of a for revenue already terms XXXX tested of patients diluted. for financial exceed To was of $XX.X loss remarks, year with $X.XX $X.XX per prepared These products, was being the which conclude entire in and company. as was million is per basic our million and both revenue $X.XX the XXXX a XXXX of number year numbers performance established record share and my performance the with $XX.X we
we Operator, to new expect quarter these currently thank highs you attain the the for support, the During I of and lines interest your company, your XXXX, in questions. please open categories. in fourth for continuing now